Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Researchers in India fought to develop what could have been the first therapy to use gene-editing to halt a rare neurodegenerative disease. The efforts hold lessons for the messy state of modern drug development.
It’s not just people with ultra-rare disorders who could benefit from hyper-personalized therapies. Scientists and regulators must work together to ensure the benefits are spread.
The Cavendish Laboratory’s director, Brian Pippard, comments on the landscape of physics research in 1974, plus the benefits of applying thermodynamics to physiology, in the weekly dip in Nature’s archive.
Deep-seated aspects of local research systems need to be uprooted to ensure that researchers in low-income countries can harness the advantages of open access.
Large language models could exhaust the supply of publicly available, human-crafted writing in the next two to eight years. Plus, AI model finds huge cache of potential antibiotics hidden in genomes and Microsoft’s algorithm predicts global air pollution in less than a minute.